news Potential SARS-CoV-2 antiviral to be tested in human lung cells 24 May 2021 | By Victoria Rees (Drug Target Review) A synthetic antiviral named R327 has shown promise in initial tests against SARS-CoV-2 and is now advancing to the next stage of in vitro studies.
news Adding RPL6 protein to vaccine prevents malaria in mice, find researchers 18 May 2020 | By Victoria Rees (Drug Target Review) Researchers have shown that adding the RPL6 protein to malaria vaccines was successful at protecting mice against the condition.